Please login to the form below

lenalidomide

This page shows the latest lenalidomide news and features for those working in and with pharma, biotech and healthcare.

FDA green lights BMS’ multiple myeloma combo

A recent phase 2 study, ELOQUENT-3, tested the combination in multiple myeloma patients who received two or more prior therapies, and were either refractory or relapsed and refractory to lenalidomide

Latest news

FDA clears first-line use for J&J’s myeloma drug Darzalex

Later on, additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated
Celgene to launch five new products through to 2020

The statements came as Celgene reported expectation-topping sales and earnings driven by Revlimid (lenalidomide) and new psoriasis therapy Otezla (apremilast).
Geron poleaxed as partner J&J abandons only pipeline drug

s broad portfolio headed by Revlimid (lenalidomide), and a clutch of new candidates coming through mid- to late-stage clinical development.
Darzalex powers ahead with frontline myeloma approval in Europe

lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated patients.
Celgene’s Revlimid gets a win in late-stage lymphoma

The AUGMENT trial paired Revlimid (lenalidomide) with Roche’s established lymphoma therapy Rituxan (rituximab) in patient with two types of NHL – follicular lymphoma (FL) and marginal zone lymphoma (MZL) – and showed

More from news
Approximately 14 fully matching, plus 82 partially matching documents found.

Latest Intelligence

Building a business that is lean and specialised

drug Revlimid (lenalidomide).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Events Manager – Med Comms – Surrey: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager / Account Director: Competative

Associate Editorial Director – Med Comms – London: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Medical Writers: Competitive Salary and Benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Associate Director: £75, 000-90, 000

Director, Market Access / HEOR - North-West: Negotiable

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Associate Medical Director: Highly Competitive

Production Manager – Healthcare Communications: DOE

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Director: Excellent benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Senior Medical Writer: Competitive Salary

Medical/ Scientific Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...